Cardiovascular and kidney outcomes of semaglutide and the annual eGFR slope in adults with and without type 2 diabetes: data extraction sheet, analysis code and search records for a systematic review and meta-analysis of randomised controlled trials

Paper No results yet Not peer reviewed

Key takeaways

This is a data file for a review of semaglutide, a diabetes drug. It is not the main study. There are no new results to report yet.

Peichen Zhang (Zhengzhou University) · Tianzhi Zang (Zhengzhou University)

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-27
https://doi.org/10.5281/zenodo.22989590